Endo Itsuro 遠藤逸朗

… Alternative Names

ENDO Itsuro 遠藤逸朗

Less

Researcher Number	10432759
Affiliation (Current)	2025: 徳島大学, 大学院医歯薬学研究部(医学域), 教授
Affiliation (based on the past Project Information) *help	2021 – 2025: 徳島大学, 大学院医歯薬学研究部(医学域), 教授 2011 – 2014: 徳島大学, 大学病院, 講師 2011: 徳島大学, 病院, 講師 2008 – 2010: 徳島大学, 大学院・ヘルスバイオサイエンス研究部, 助教
Review Section/Research Field	Principal Investigator Basic Section 54040:Metabolism and endocrinology-related / Basic Section 52010:General internal medicine-related Except Principal Investigator Endocrinology / Basic Section 57060:Surgical dentistry-related / Hematology / Metabolomics
Keywords	Principal Investigator ステロイド骨粗鬆症 / TAK1 / サルコペニア / Myostatin / 炎症性サイトカイン誘導性筋障害 / 骨格筋萎縮 / 炎症性サイトカイン / TAK1阻害 Except Principal Investigator 多発性骨髄腫 / 骨芽細胞 … More / 骨髄腫 / Wntシグナル / 老化 / 骨細胞 / 骨転移 / 脂質 / シグナル伝達 / 遺伝子 / Pim-2 / 破骨細胞 / 脂肪細胞 / インターロイキン-11 (IL-11) / アポトーシス / 薬剤耐性 / Pimキナーゼ / 骨病変 / 血液腫瘍学 / 2型糖尿病 / メタボリックシンドローム / インスリン抵抗性 / 心筋リモデリング / トロンビン / ヘパリンコファクターII / アンドロゲン / interleukin-11 / 動脈硬化 / 糖尿病 / 骨粗鬆症 / 内科 Less

ステロイド骨粗鬆症へのSema3A, IL-11の関与と新規治療への応用Principal Investigator
- Principal Investigator
  
  遠藤逸朗
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54040:Metabolism and endocrinology-related
- Research Institution
  The University of Tokushima
骨細胞保護によるがんの骨転移新規治療戦略の開発
- Principal Investigator
  
  日浅雅博
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 57060:Surgical dentistry-related
- Research Institution
  The University of Tokushima
Inflammatory cytokine-induced muscle atrophy and weakness can be ameliorated by an inhibition of TGF-beta-activated kinase-1Principal Investigator
- Principal Investigator
  
  ENDO Itsuro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  The University of Tokushima
Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders
- Principal Investigator
  
  MATSUMOTO Toshio
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Endocrinology
- Research Institution
  The University of Tokushima
Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interaction
- Principal Investigator
  
  ABE Masahiro
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  The University of Tokushima
Pathophysiological roles of heparin cofactor II in cardiac remodeling and insulin resistance
- Principal Investigator
  
  AIHARA Ken-ichi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Metabolomics
- Research Institution
  The University of Tokushima
Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems
- Principal Investigator
  
  MATSUMOTO Toshio
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Endocrinology
- Research Institution
  The University of Tokushima

All 2024 2023 2015 2014 2013 2012 2011 2010 2009 2008 Other

All Journal Article Presentation

[Journal Article] Bone-fat linkage via interleukin-11 in response to mechanical loading2024
- Author(s)
  Hiasa M, Endo I, Matsumoto T.
- Journal Title
  
  Journal of Bone and Mineral Metabolism
  
  Volume: - Issue: 4 Pages: 447-454
- DOI
  10.1007/s00774-023-01493-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K27791
[Journal Article] Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors2024
- Author(s)
  Sogabe K、Nakamura S、Higa Y、Miki H、Oda A、Maruhashi T、Sumitani R、Oura M、Takahashi M、Nakamura M、Maeda Y、Hara T、Yamagami H、Fujii S、Kagawa K、Ozaki S、Kurahashi K、Endo I、Aihara K、Nakaue E、Hiasa M、Teramachi J、Harada T、Abe M
- Journal Title
  
  International Journal of Hematology
  
  Volume: 119 Issue: 3 Pages: 303-315
- DOI
  10.1007/s12185-023-03705-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K27791
[Journal Article] Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors2023
- Author(s)
  Nakaue Emiko、Teramachi Jumpei、Tenshin Hirofumi、Hiasa Masahiro、Harada Takeshi、Oda Asuka、Inoue Yusuke、Shimizu So、Higa Yoshiki、Sogabe Kimiko、Oura Masahiro、Hara Tomoyo、Sumitani Ryohei、Maruhashi Tomoko、Yamagami Hiroki、Endo Itsuro、Tanaka Eiji、Abe Masahiro
- Journal Title
  
  International Journal of Hematology
  
  Volume: - Issue: 1 Pages: 88-98
- DOI
  10.1007/s12185-023-03601-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-23K15975, KAKENHI-PROJECT-23K19694, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K27791
[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2015
- Author(s)
  Hiasa M, Teramachi J, Oda A, Amachi R, Harada T, Nakamura S, Miki H, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M.
- Journal Title
  
  Leukemia
  
  Volume: 29 Pages: 207-217
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293215
[Journal Article] Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).2015
- Author(s)
  Dong B, Endo I, Ohnishi Y, Kondo T, Hasegawa T, Amizuka N, Kiyonari H, Shioi G, Abe M, Fukumoto S, Matsumoto T.
- Journal Title
  
  J Bone Miner Res
  
  Volume: 30 Pages: 1980-1993
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293215
[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2014
- Author(s)
  Hiasa M, Jumpei T, Oda A, Amachi R, Harada T, Nakamura S, Miki S, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M.
- Journal Title
  
  Leukemia
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293215
[Journal Article] High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.2014
- Author(s)
  Yagi S, Aihara K, Kondo T, Endo I, Hotchi J, Ise T, Iwase T, Akaike M, Matsumoto T, Sata M
- Journal Title
  
  Endocr J
  
  Volume: 61 Pages: 727-733
- NAID
  130004443979
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25293215
[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma2014
- Author(s)
  Hiasa M, Jumpei T, Oda A, Amachi R, Harada T, Nakamura S, Miki S, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M
- Journal Title
  
  Leukemia
  
  Volume: (Epub ahead of print)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591390
[Journal Article] Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.2013
- Author(s)
  Kuriwaka-Kido R, Kido S, Miyatani Y, Ito Y, Kondo T, Omatsu T, Dong B, Endo I, Miyamoto K, Matsumoto T
- Journal Title
  
  Endocrinology
  
  Volume: 154 Pages: 1156-1167
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293215
[Journal Article] Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study2013
- Author(s)
  Kato S, Endo I, Fujimura M, Kuriwaka-Kido R, Fujinaka Y, Aihara K, Iwase T, Inoue D, Akaike M, Abe M, Matsumoto T
- Journal Title
  
  Atherosclerosis
  
  Volume: 229 Issue: 1 Pages: 182
- DOI
  10.1016/j.atherosclerosis.2013.03.030
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591390
[Journal Article] Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study.2013
- Author(s)
  Kato S, Endo I, Fujimura M, Kuriwaka-Kido R, Fujinaka Y, Aihara K, Iwase T, Inoue D, Akaike M, Abe M, Matsumoto T.
- Journal Title
  
  Atherosclerosis
  
  Volume: 229 Pages: 182-185
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591390
[Journal Article] Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors2012
- Author(s)
  Ikegame A, Ozaki S, Tsuji D, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Watanabe K, Hiasa M, Kimura N, Kikuchi Y, Sakamoto A, Habu K, Endo M, Itoh K, Yamada-Okabe H, MatsumotoT
- Journal Title
  
  Leukemia
  
  Volume: 26 Issue: 9 Pages: 2124-2134
- DOI
  10.1038/leu.2012.78
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790318, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
[Journal Article] The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells2011
- Author(s)
  Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K, Sakai A, Ozaki S, Matsumoto T, Abe M
- Journal Title
  
  Leukemia
  
  Volume: 25 Issue: 7 Pages: 1182-1188
- DOI
  10.1038/leu.2011.60
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
[Journal Article] The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells2011
- Author(s)
  Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K-I, Sakai A, Ozaki S, Matsumoto T, Abe M
- Journal Title
  
  Leukemia in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Vitamin D Insufficiency Defined by Serum 25-Hydroxyvitamin D and Parathyroid Hormone Before and After Oral Vitamin D3 Load in Japanese Subjects.2011
- Author(s)
  Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D, Endo I, Okano T, Hirota T, Matsumoto T
- Journal Title
  
  J Bone Miner Metab 29
  
  Pages: 103-110
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Validation of the Japanese Osteoporosis Quality of Life Questionnaire.2010
- Author(s)
  Kumamoto K, Nakamura T, Suzuki T, Gorai I, Fujinawa O, Ohta H, Shiraki M, Yoh K, Fujiwara S, Endo N, Matsumoto T
- Journal Title
  
  J Bone Miner Metab 28
  
  Pages: 1-7
- NAID
  10027206383
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Mechanical Stress Activates Smad Pathway through PKC δ to Enhance Interleukin-11 Gene Transcription in Osteoblasts.2010
- Author(s)
  Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, Endo I, Inoue D, Taniguchi H, Inoue Y, Imamura T, Matsumoto T
- Journal Title
  
  PLoS ONE 5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients Proposal of diagnostic criteriausing FGF23 measurement.2008
- Author(s)
  Endo, I
- Journal Title
  
  Bone 42(6)
  
  Pages: 1235-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Causes and differential diagnosis of hypocalcemia -Recommendation proposed by expert panel supported by Ministry of Health, Labour and Welfare, Japan-.2008
- Author(s)
  Fukumoto, Namba N, Ozono K, Yamauchi M, Sugimoto T, Michigami T, Tanaka H, Inoue D, Minagawa M, Endo I, Matsumoto T
- Journal Title
  
  Endocr J 55
  
  Pages: 787-794
- NAID
  10024422564
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Journal Article] Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients Proposal of diagnostic criteria using FGF23 measurement.2008
- Author(s)
  Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T
- Journal Title
  
  Bone 42
  
  Pages: 1235-1239
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] 炎症性サイトカイン誘導性の筋萎縮、筋力低下はTAK1阻害により改善する2024
- Author(s)
  遠藤逸朗,金井麻衣, Byambasuren Ganbaatar,寺町順平,日浅雅博，天真寛文，比嘉　佳基, 原倫世, 原田武志，瀬部　真由，堤理恵, 阪上　浩, 松本俊夫，安倍正博
- Organizer
  第42回日本骨代謝学会
- Data Source
  KAKENHI-PROJECT-21K07339
[Presentation] TAK1阻害による炎症性サイトカイン誘導性骨格筋障害の改善2023
- Author(s)
  金井麻衣,遠藤逸朗,大西幸代, Byambasuren Ganbaatar, 寺町順平,原倫世,瀬部真由,阪上浩,福本誠二,松本俊夫, 安倍正博
- Organizer
  第96回日本内分泌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07339
[Presentation] Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: therapeutic impact of TAK-1 inhibition.2015
- Author(s)
  umpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe.
- Organizer
  Annual Meeting of the American Society for Bone and Mineral Research
- Place of Presentation
  Seattle, WA. (USA)
- Year and Date
  2015-10-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293215
[Presentation] RAIL is not a proapoptotic but rather anti-apoptotic mediator for osteoclasts to stimulate their differentiation and survival.2015
- Author(s)
  Hirohfumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Keiishiro Watanabe, Singen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto, Masahiro Abe.
- Organizer
  Annual Meeting of the American Society for Bone and Mineral Research
- Place of Presentation
  Seattle, WA. (USA)
- Year and Date
  2015-10-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293215
[Presentation] Serum ICTP can be a surrogate marker of coronary unstable plaques2010
- Author(s)
  遠藤逸朗
- Organizer
  ASBMR 2010 Annual Meeting
- Place of Presentation
  Metro Toronto Convention
- Year and Date
  2010-10-15
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] 常染色体優性低Ca血症(ADH)に対するcalcilyticsの治療応用への可能性2009
- Author(s)
  遠藤逸朗
- Organizer
  第27回日本骨代謝学会学術集会
- Place of Presentation
  大阪市(大阪国際会議場)
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] A new calcilytic compound, JTT-305, inhibits enhanced signaling by activating mutations of calcium-sensing receptor in autosomal dominant hypocalcemia (ADH)2009
- Author(s)
  遠藤逸朗
- Organizer
  6^<th> Meeting of Bone Biology Forum
- Place of Presentation
  静岡県裾野市(冨士教育研究所)
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] A new calcilytic compound, JTT-305, inhibits enhanced signaling by activating mutations of calcium-sensing receptor in autosomal dominant hypocalcemia(ADH)2009
- Author(s)
  遠藤逸朗
- Organizer
  American Society for Bone and Mineral Research 31th Annual Meeting
- Place of Presentation
  米国(Denver)Colorado Convention Center
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] A new calcilytic compound, JTT-305, inhibits enhanced signaling by activating mutations of calcium-sensing receptor in autosomal dominant hypocalce mia (ADH)2009
- Author(s)
  遠藤逸朗
- Organizer
  American Society for Bone and Mineral Research31th Annual Meeting
- Place of Presentation
  Denver Convention Center
- Year and Date
  2009-09-16
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] 冠動脈不安定プラーク予測因子としてのICTP2009
- Author(s)
  遠藤逸朗
- Organizer
  第82回日本内分泌学会学術集会
- Place of Presentation
  群馬県(群馬県民会館前橋商工会議所)
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] 脳波への徐消化を伴う重症低血糖昏睡を来した神経性食思不振症の一例2009
- Author(s)
  遠藤逸朗
- Organizer
  第9回日本内分泌学会四国支部学術集会
- Place of Presentation
  愛媛県松山市(総合コミュニティセンター)
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] 常染色体優性低Ca血症(ADH)に対するcalcilyticsの治療応用への可能性2009
- Author(s)
  遠藤逸朗
- Organizer
  第27回日本骨代謝学会学術集会
- Place of Presentation
  大阪市(大阪国際会議場)
- Year and Date
  2009-07-23
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients-Proposal of diagnostic criteria using FGF23 measurement2008
- Author(s)
  遠藤逸朗
- Organizer
  ASBMR 2008
- Place of Presentation
  モントリオール
- Year and Date
  2008-09-13
- Data Source
  KAKENHI-PROJECT-20249050
[Presentation] Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combination with the proteasome inhibitor bortezomib.
- Author(s)
  Keiichiro Watanabe, Masahiro Abe, Hiroshi Mori, Ryota Amachi, Masahiro Hiasa, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto.
- Organizer
  35th Annual Meeting, the American Society for Bone and Mineral Research, Baltimore
- Place of Presentation
  Baltimore Convention Center（Baltimore, Maryland, USA）
- Data Source
  KAKENHI-PROJECT-25293215
[Presentation] Effect of a calcilytic compound in autosomal dominant hypocalcemia model mice.
- Author(s)
  Bingzi Dong, Itsuro Endo, Takeshi Kondo, Yukiyo Ohnishi, Masahiro Abe, Seiji Fukumoto, Tomoka Hasegawa, Norio Amizuka, Shin-ichi Aizawa, Toshio Matsumoto
- Organizer
  American Society of Bone and Mineral Research
- Place of Presentation
  Houston (USA)
- Year and Date
  2014-09-12 – 2014-09-15
- Data Source
  KAKENHI-PROJECT-25293215
[Presentation] Interleukin-11 is an important factor for mechanical stress-induced osteoblast differentiation and bone formation.
- Author(s)
  Takeshi Kondo, Bingzi Dong, Takashi Omatsu, Yukiyo Ohnishi, Itsuro Endo, Masahiro Abe, Shinichi Aizawa, Hiroshi Sakaue, Toshio Matsumoto
- Organizer
  American Society of Bone and Mineral Research
- Place of Presentation
  Houston (USA)
- Year and Date
  2014-09-12 – 2014-09-15
- Data Source
  KAKENHI-PROJECT-25293215

1. ABE Masahiro (80263812)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
2. AIHARA Kenichi (70372711)

# of Collaborated Projects: 3 results

# of Collaborated Products: 1 results
3. FUJINAKA Yuichi (30432751)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. MATSUMOTO Toshio (20157374)

# of Collaborated Projects: 2 results

# of Collaborated Products: 16 results
5. 金井麻衣 (90836470)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
6. 日浅雅博 (90511337)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
7. AKAIKE Masashi (90271080)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. IWASE Takashi (10403718)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. FUKUMOTO Seiji (30202287)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 倉橋清衛 (30567342)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 原田武志 (10618359)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 寺町順平 (20515986)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
13. 米田俊之 (80142313)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 沢津橋俊 (70535103)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 原倫世 (80968305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. TSUJI Daisuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 安部正博

# of Collaborated Projects: 0 results

# of Collaborated Products: 14 results

Endo Itsuro 遠藤 逸朗

ENDO Itsuro 遠藤 逸朗

Research Projects

Research Products

Co-Researchers

ステロイド骨粗鬆症へのSema3A, IL-11の関与と新規治療への応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

骨細胞保護によるがんの骨転移新規治療戦略の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Inflammatory cytokine-induced muscle atrophy and weakness can be ameliorated by an inhibition of TGF-beta-activated kinase-1Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interaction

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Pathophysiological roles of heparin cofactor II in cardiac remodeling and insulin resistance

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Bone-fat linkage via interleukin-11 in response to mechanical loading2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2015

Author(s)

Journal Title

Data Source

[Journal Article] Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).2015

Author(s)

Journal Title

Data Source

[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2014

Author(s)

Journal Title

Data Source

[Journal Article] High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.2014

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma2014

Endo Itsuro 遠藤逸朗

ENDO Itsuro 遠藤逸朗